Arrhythmias & electrophysiology
Very-early symptomatic recurrence is associated with late recurrence after radiofrequency ablation of atrial fibrillation
Authors' conclusion
Very-early symptomatic recurrence is associated with an increased risk of LR.
Study context
- Population
- Atrial fibrillation (AF) patients undergoing first radiofrequency catheter ablation, Beijing Anzhen Hospital, June 2018–December 2021330 (4.79%) with VESR
- Participants
- 6,887 patients
- Exposure
- VESR and/or ER vs neither, after first radiofrequency catheter ablation (RFCA) of AF
- Outcome
- Late recurrence (after 3 months of RFCA)
- Follow-up
- Average 14.7 months after grouping
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
Late recurrence
Fold increase in LR risk (multivariate)
2.161
Group B
Fold increase in LR risk (multivariate)
5.409
Group C
Fold increase in LR risk (multivariate)
7.401
Group D
Observational data: associations, not effects.
Further findings
| Outcome | Fold LR risk | P value |
|---|---|---|
| Late recurrence, by AF type (subgroup)VESR vs other patients · paroxysmal AF | P < 0.001 | |
| Late recurrence, by AF type (subgroup)VESR vs other patients · persistent AF | P < 0.001 | |
| Late recurrence, by VESR modeVESR-atrial tachycardia vs Group A | 3.467 | |
| Late recurrence, by VESR modeVESR-AF vs Group A | 5.564 |
- Late recurrence, by AF type (subgroup): P for interaction = 0.118
Prediction of LR in VESR patients
- Classification based on ER and VESR modes improved prediction of LR risk
Original publication
Very-early symptomatic recurrence is associated with late recurrence after radiofrequency ablation of atrial fibrillation. Europace. Published 7 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →